| # | Drug | Count |
|---|---|---|
| 0 | METRONIDAZOLE | 13 |
| 1 | METRONIDAZOLE TOPICAL | 13 |
| 2 | PREDNISOLONE | 12 |
| 3 | PREDNISOLONE ORAL | 12 |
| 4 | PREDNISOLONE ORAL SOLUTION | 12 |
| 5 | RITUXIMAB | 12 |
| 6 | TACROLIMUS | 11 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 11 |
| 8 | TACROLIMUS OINTMENT 0.1% | 11 |
| 9 | PREDNISONE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PYRIMETHAMINE | 6 | 0.0047 |
| 1 | TINIDAZOLE | 1 | 0.0023 |
| 2 | CLINDAMYCIN PHOSPHATE | 6 | 0.0011 |
| 3 | PENTAMIDINE ISETHIONATE | 1 | 0.0008 |
| 4 | ATOVAQUONE | 6 | 0.0007 |
| 5 | REMDESIVIR | 5 | 0.0004 |
| 6 | BASILIXIMAB | 4 | 0.0003 |
| 7 | METRONIDAZOLE TOPICAL | 13 | 0.0003 |
| 8 | MYCOPHENILIC ACID | 5 | 0.0002 |
| 9 | METRONIDAZOLE | 13 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 6 | 0.0047 |
| 1 | Antimalarial [EPC] | 6 | 0.0006 |
| 2 | Antiprotozoal [EPC] | 6 | 0.0006 |
| 3 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 5 | 0.0004 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 5 | 0.0002 |
| 5 | Nitroimidazole Antimicrobial [EPC] | 13 | 0.0002 |
| 6 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 7 | Protease Inhibitor [EPC] | 3 | 0.0001 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 9 | Nucleoside Analog Antiviral [EPC] | 5 | 0.0001 |